Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer
Purpose Sleeve lobectomy is a safe and effective surgical procedure for centrally located non-small cell lung cancer (NSCLC). However, the use of video-assisted thoracoscopic surgery (VATS) on bronchial sleeve resection is still controversial due to a lack of evidence. In this study, we describe our...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sungkyunkwan University School of Medi
2021-03-01
|
Series: | Precision and Future Medicine |
Subjects: | |
Online Access: | http://www.pfmjournal.org/upload/pdf/pfm-2020-00184.pdf |
id |
doaj-1a1855abcd0c416a829f2d7973432d7a |
---|---|
record_format |
Article |
spelling |
doaj-1a1855abcd0c416a829f2d7973432d7a2021-04-16T05:41:04ZengSungkyunkwan University School of MediPrecision and Future Medicine2508-79402508-79592021-03-0151414710.23838/pfm.2020.0018493Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancerYeong Jeong Jeon0Jeonghee Yun1Yong Soo Choi2Min Soo Kim3Jae Won Choi4 Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaPurpose Sleeve lobectomy is a safe and effective surgical procedure for centrally located non-small cell lung cancer (NSCLC). However, the use of video-assisted thoracoscopic surgery (VATS) on bronchial sleeve resection is still controversial due to a lack of evidence. In this study, we describe our experience on VATS sleeve lobectomy and evaluate its feasibility for treating NSCLC. Methods From January 2010 to May 2019, VATS sleeve lobectomy was attempted in 19 patients with NSCLC at Samsung Medical Center. Their baseline characteristics, perioperative data, and survival outcome were collected and analyzed retrospectively. Results Of the 19 patients, 10 underwent VATS sleeve lobectomy successfully. The mean age of the patients who underwent successful VATS was 53.5± 15.8 years, and all the patients were men. Seven patients (70%) had squamous cell carcinoma. The mean postoperative chest tube drainage duration was 5.3± 2.3 days, and the median hospital stay duration was 7 days (interquartile range, 6.25 to 11.5 days). Among the patients who underwent successful VATS, two had postoperative bronchial stenosis: One patient underwent complete pneumonectomy, and one patient was observed without any intervention. During the median follow-up duration of 3.5 years, two patients with squamous cell carcinoma who underwent successful VATS died. Of these, one died 70 days postoperatively because of acute respiratory distress syndrome and one died 18 months postoperatively from an unknown cause. No patient had locoregional recurrence. Conclusion VATS sleeve lobectomy is a feasible surgical procedure for centrally located tumors without vascular invasion.http://www.pfmjournal.org/upload/pdf/pfm-2020-00184.pdfthoracic surgery, video-assistedsleeve lobectomycarcinoma, non-small-cell lung |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yeong Jeong Jeon Jeonghee Yun Yong Soo Choi Min Soo Kim Jae Won Choi |
spellingShingle |
Yeong Jeong Jeon Jeonghee Yun Yong Soo Choi Min Soo Kim Jae Won Choi Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer Precision and Future Medicine thoracic surgery, video-assisted sleeve lobectomy carcinoma, non-small-cell lung |
author_facet |
Yeong Jeong Jeon Jeonghee Yun Yong Soo Choi Min Soo Kim Jae Won Choi |
author_sort |
Yeong Jeong Jeon |
title |
Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer |
title_short |
Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer |
title_full |
Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer |
title_fullStr |
Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer |
title_full_unstemmed |
Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer |
title_sort |
feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer |
publisher |
Sungkyunkwan University School of Medi |
series |
Precision and Future Medicine |
issn |
2508-7940 2508-7959 |
publishDate |
2021-03-01 |
description |
Purpose Sleeve lobectomy is a safe and effective surgical procedure for centrally located non-small cell lung cancer (NSCLC). However, the use of video-assisted thoracoscopic surgery (VATS) on bronchial sleeve resection is still controversial due to a lack of evidence. In this study, we describe our experience on VATS sleeve lobectomy and evaluate its feasibility for treating NSCLC. Methods From January 2010 to May 2019, VATS sleeve lobectomy was attempted in 19 patients with NSCLC at Samsung Medical Center. Their baseline characteristics, perioperative data, and survival outcome were collected and analyzed retrospectively. Results Of the 19 patients, 10 underwent VATS sleeve lobectomy successfully. The mean age of the patients who underwent successful VATS was 53.5± 15.8 years, and all the patients were men. Seven patients (70%) had squamous cell carcinoma. The mean postoperative chest tube drainage duration was 5.3± 2.3 days, and the median hospital stay duration was 7 days (interquartile range, 6.25 to 11.5 days). Among the patients who underwent successful VATS, two had postoperative bronchial stenosis: One patient underwent complete pneumonectomy, and one patient was observed without any intervention. During the median follow-up duration of 3.5 years, two patients with squamous cell carcinoma who underwent successful VATS died. Of these, one died 70 days postoperatively because of acute respiratory distress syndrome and one died 18 months postoperatively from an unknown cause. No patient had locoregional recurrence. Conclusion VATS sleeve lobectomy is a feasible surgical procedure for centrally located tumors without vascular invasion. |
topic |
thoracic surgery, video-assisted sleeve lobectomy carcinoma, non-small-cell lung |
url |
http://www.pfmjournal.org/upload/pdf/pfm-2020-00184.pdf |
work_keys_str_mv |
AT yeongjeongjeon feasibilityofvideoassistedthoracoscopicsleevelobectomyfornonsmallcelllungcancer AT jeongheeyun feasibilityofvideoassistedthoracoscopicsleevelobectomyfornonsmallcelllungcancer AT yongsoochoi feasibilityofvideoassistedthoracoscopicsleevelobectomyfornonsmallcelllungcancer AT minsookim feasibilityofvideoassistedthoracoscopicsleevelobectomyfornonsmallcelllungcancer AT jaewonchoi feasibilityofvideoassistedthoracoscopicsleevelobectomyfornonsmallcelllungcancer |
_version_ |
1721525428758249472 |